PEAK6 Group’s Cytosorbents Corp CTSO Stock Holding History

PEAK6 Group’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$168K	Buy	+737	New	+$140K	﹤0.01%	3446
2018 Q1	–	Sell	-4,987	Closed	-$648K	–	4417
2017 Q4	$648K	Buy	4,987 +1,256	+34%	+$160K	﹤0.01%	2264
2017 Q3	$463K	Buy	3,731 +2,669	+251%	+$272K	﹤0.01%	2605
2017 Q2	$91K	Buy	1,062 +162	+18%	+$14.2K	﹤0.01%	3894
2017 Q1	$81K	Buy	+900	New	+$101K	﹤0.01%	3680
2015 Q4	–	Sell	-1	Closed	–	–	4832
2015 Q3	$0	Buy	+1	New	+$133	﹤0.01%	5183

Other funds holding CTSO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MHP

Manatuck Hill Partners Westport, Connecticut $302M AUM 117.41% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

PEAK6 Group's CTSO Position: Q2 2018 in Review

PEAK6 Group opened a new position in Cytosorbents Corp (CTSO) in Q2 2018: 737 shares worth $168K. The stake represents ﹤0.01% of the portfolio and ranks #3446 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in CTSO as recently as Q4 2017.

PEAK6 Group first reported a position in CTSO in Q3 2015 and has held it in 6 quarters since. The position peaked at $648K in Q4 2017. 75 funds tracked by Wall St. Rank hold CTSO as of Q2 2018.

PEAK6 Group held 737 shares of Cytosorbents Corp worth $168K as of Q2 2018.
Cytosorbents Corp was a new PEAK6 Group position in Q2 2018.
Cytosorbents Corp made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3446 holding.
PEAK6 Group first reported a position in Cytosorbents Corp in Q3 2015 and has held it in 6 quarters since.
PEAK6 Group's Cytosorbents Corp position peaked at $648K in Q4 2017.
75 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.